Does BEVACIZUMAB Cause Neoplasm progression? 933 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 933 reports of Neoplasm progression have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 1.2% of all adverse event reports for BEVACIZUMAB.
933
Reports of Neoplasm progression with BEVACIZUMAB
1.2%
of all BEVACIZUMAB reports
305
Deaths
168
Hospitalizations
How Dangerous Is Neoplasm progression From BEVACIZUMAB?
Of the 933 reports, 305 (32.7%) resulted in death, 168 (18.0%) required hospitalization, and 29 (3.1%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 933 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which BEVACIZUMAB Alternatives Have Lower Neoplasm progression Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ